Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion

Astrazeneca

  • Google Deepmind among nominees for ‘Nobel Prize of engineering’

    June 28, 2024

    AI-powered weather forecasting, innovative heat batteries and the rapid manufacturing scale-up of a Covid vaccine are the three cutting edge technologies nominated for an engineering award dubbed "the Nobel Prize of Engineering".

  • Oxford Biomedica issues new shares to secure a £17m investment

    June 18, 2024

    Cell and gene therapy company Oxford Biomedica has announced a near £17m investment which will see it issue new shares to the London Stock Exchange.

  • Astrazeneca swallows up Canada-based Fusion Pharmaceuticals in £1.5bn move

    June 5, 2024

    Astrazeneca has completed its $2bn (£1.5bn) acquisition of Canada-based Fusion Pharmaceuticals, in a deal first announced in March.

  • ‘New era of growth’: FTSE 100 giant Astrazeneca aims to double revenue

    May 21, 2024

    London-listed Astrazeneca reported revenue of $45.8bn in 2023 and growth of 19 per cent to $12.7bn in the first quarter of 2024.

  • Astrazeneca to build huge new cancer drug plant in Singapore

    May 20, 2024

    Astrazeneca has said it will invest $1.5bn (£1.2bn) to build a manufacturing facility in Singapore to produce antibody drug conjugates (ADCs), a next-generation cancer treatment.

  • Astrazeneca: London-listed pharma giant heralds successful breast cancer drug

    April 29, 2024

    Astrazeneca has found that Enhertu helped patients live longer without their breast cancer getting worse compared to standard chemotherapy.

  • Astrazeneca’s revenue surges as pipeline investments pay off

    April 25, 2024

    Pascal Soriot, chief executive officer of AstraZeneca, said: "Astrazeneca had a very strong start in 2024 with substantial total revenue growth of 19 per cent in the first quarter.

  • Angle agrees deal with Astrazeneca for tech to kill cancer cells

    April 24, 2024

    This is expected to be driven by an increase in the use of combination therapy for the treatment of drug-resistant cancers and the need for novel targeted medicines for cancer treatment. 

  • How much is too much? The CEO pay predicament

    April 23, 2024

    A growing number of London-listed companies have been asking shareholders to approve radical pay rises for their top execs. Why?

  • Global top 50 companies: UK absent as American tech triumphs

    April 22, 2024

    There are now no UK companies among the top 50 largest listed companies in the world, as the British economy has struggled to compete with the dominance of American tech firms.

Posts pagination

  • Previous
  • Page 1
  • …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • …
  • Page 27
  • Next

Trending Articles

  • Revealed: Secret Treasury plan to tax State Pension before it is paid out

  • Two solicitors linked to Post Office scandal charged with misconduct

  • Burnham’s new chief of staff ran City firm advising Thames Water and rival Heathrow bidder

  • Barclays and Lloyds join banking sector plan for digital ID

  • Clarkson’s Farm and why businesses must stop blaming the weather

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM. All rights reserved.
About · Contact · Terms · Privacy